Impact of obesity in the setting of high-dose chemotherapy.
about
Effect of body mass in children with hematologic malignancies undergoing allogeneic bone marrow transplantation.Description of current practices of empiric chemotherapy dose adjustment in obese adult patients.Association between baseline body mass index and overall survival among patients over age 60 with acute myeloid leukemiaEvaluation of chemotherapy-induced severe myelosuppression incidence in obese patients with capped dosing.Chemotherapy dose adjustment for obese patients undergoing hematopoietic stem cell transplantation: a survey on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Effect of obesity on outcomes after autologous hematopoietic stem cell transplantation for multiple myeloma.Cardiac toxicity of high-dose chemotherapy.Relationship between obesity and clinical outcome in adults with acute myeloid leukemia: A pooled analysis from four CALGB (alliance) clinical trialsStearoyl gemcitabine nanoparticles overcome obesity-induced cancer cell resistance to gemcitabine in a mouse postmenopausal breast cancer model.BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications.Effect of weight on outcomes of children undergoing hematopoietic cell transplantation.Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size.Dosing of chemotherapy in obese and cachectic patients: results of a national survey.Effectiveness and toxicity of high-dose cyclophosphamide in obese versus non-obese patients receiving allogeneic hematopoietic stem cell transplant.Treatment modifications of antineoplastic drugs in an oncology day-care unit.Impact of being overweight on outcomes of hematopoietic SCT: a meta-analysis.Endogenous glucagon-like peptide- 1 and 2 are essential for regeneration after acute intestinal injury in mice.
P2860
Q33697246-B0F866FE-6BF4-4945-A910-893B98434FF4Q33846184-FC63CC2E-A05E-499B-98B4-71F5C75CEB2FQ34428550-2625B9D0-EE02-429C-AA24-A98C9697BD8FQ34459665-D259E1DA-EC7D-4002-BB9D-4D2091A407BDQ34959952-37236909-ECD2-47B0-9353-1BC22CA61CEBQ35219011-E0C58FDB-588E-40A6-B071-CC4971BA99DEQ35949084-97E75F5A-FB54-4574-8A25-66CC9FC62E98Q36494308-326AF3DF-EC6F-4793-BAEB-CFC521F96A9DQ36887757-A50004D5-5983-43F3-8BED-4641F9F084E3Q37675281-2FFB5C06-1E73-4FAE-BE57-8CD3ACCC5FB7Q38063272-82E1E4BC-8A32-45AE-B33C-85203466CD0AQ43407581-5C0E6134-D74C-451F-A4DC-D384FC4EEDE8Q44317811-37195E06-B316-4A42-889D-38C05853BC2BQ45003576-FF26BEF2-B91B-4512-A495-11F3F2F2C932Q48594210-FDE9A06C-09AB-4974-A43D-5AA5A45492BDQ53093941-E8CAF976-1B37-43F1-8A89-997E8C11BC87Q55280611-A5832F3A-F915-4511-84B7-A4A9960F870A
P2860
Impact of obesity in the setting of high-dose chemotherapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Impact of obesity in the setting of high-dose chemotherapy.
@ast
Impact of obesity in the setting of high-dose chemotherapy.
@en
type
label
Impact of obesity in the setting of high-dose chemotherapy.
@ast
Impact of obesity in the setting of high-dose chemotherapy.
@en
prefLabel
Impact of obesity in the setting of high-dose chemotherapy.
@ast
Impact of obesity in the setting of high-dose chemotherapy.
@en
P2860
P356
P1476
Impact of obesity in the setting of high-dose chemotherapy.
@en
P2093
Navarro WH
P2860
P2888
P304
P356
10.1038/SJ.BMT.1704052
P407
P577
2003-06-01T00:00:00Z
P5875
P6179
1040729559